Publications

Chloroquine-resistant Plasmodium falciparum infections among UK travellers returning with malaria after chloroquine prophylaxis.

SUTHERLAND, CJ; Haustein, T; Gadalla, N; Armstrong, M; Doherty, JF; CHIODINI, PL;

2007

The Journal of antimicrobial chemotherapy, (2007).59 6 10.1093/jac/dkm104.

Impact of joined-up HIV harm reduction and multidrug resistant tuberculosis control programmes in Estonia: System dynamics simulation model.

Atun, RA; Lebcir, RM; McKee, M; Habicht, J; COKER, RJ;

2007

Health policy (Amsterdam, Netherlands), (2007).81 2-3 10.1016/j.healthpol.2006.05.021.

Effects of piperaquine, chloroquine, and amodiaquine on drug uptake and of these in combination with dihydroartemisinin against drug-sensitive and -resistant Plasmodium falciparum strains.

FIVELMAN, QL; Adagu, IS; WARHURST, DC;

2007

Antimicrobial agents and chemotherapy, (2007).51 6 10.1128/AAC.01479-06.

Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria.

Humphreys, GS; Merinopoulos, I; Ahmed, J; WHITTY, CJ M; Mutabingwa, TK; SUTHERLAND, CJ; Hallett, RL;

2006

Antimicrobial agents and chemotherapy, (2006).51 3 10.1128/AAC.00875-06.

Epidemiological dynamics of antimonial resistance in Leishmania donovani: genotyping reveals a polyclonal population structure among naturally-resistant clinical isolates from Nepal.

Laurent, T; Rijal, S; YARDLEY, V; CROFT, S; De Doncker, S; Decuypere, S; Khanal, B; Singh, R; Schönian, G; Kuhls, K; Chappuis, F; Dujardin, J-C;

2006

Infection, genetics and evolution, (2006).7 2 10.1016/j.meegid.2006.08.005.

Deletion of the Trypanosoma brucei superoxide dismutase gene sodb1 increases sensitivity to nifurtimox and benznidazole.

Prathalingham, SR; Wilkinson, SR; Horn, D; KELLY, JM;

2006

Antimicrobial agents and chemotherapy, (2006).51 2 10.1128/AAC.01360-06.

Synthesis of N1-arylidene-N2-quinolyl- and N2-acrydinylhydrazones as potent antimalarial agents active against CQ-resistant P. falciparum strains.

Gemma, S; Kukreja, G; Fattorusso, C; Persico, M; Romano, MP; Altarelli, M; Savini, L; Campiani, G; Fattorusso, E; Basilico, N; Taramelli, D; YARDLEY, V; Butini, S;

2006

Bioorganic & medicinal chemistry letters, (2006).16 20 10.1016/j.bmcl.2006.07.060.

Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes.

Swarthout, TD; Van den Broek, IV; Kayembe, G; Montgomery, J; Pota, H; ROPER, C;

2006

Tropical medicine & international health, (2006).11 10 10.1111/j.1365-3156.2006.01710.x.

Defining the origin of Plasmodium falciparum resistant dhfr isolates in Senegal.

Ndiaye, D; Daily, JP; Sarr, O; Ndir, O; Gaye, O; Mboup, S; ROPER, C; Wirth, DF;

2006

Acta tropica, (2006).99 1 10.1016/j.actatropica.2006.07.002.

Randomised trial of chloroquine/sulphadoxine-pyrimethamine in Gambian children with malaria: impact against multidrug-resistant P. falciparum.

Dunyo, S; Ord, R; Hallett, R; Jawara, M; Walraven, G; Mesa, E; Coleman, R; Sowe, M; ALEXANDER, N; TARGETT, GA T; Pinder, M; SUTHERLAND, CJ;

2006

PLoS clinical trials, (2006).1 3 10.1371/journal.pctr.0010014.